Table 5.
Treatment, outcomes, and serum itraconazole levels of 12 HIV-infected patients who had histoplasmosis and TB and received itraconazole
| Treatment | Number (%) | Itraconazole levels | Outcome | |
|---|---|---|---|---|
| Level (μg/mL) | Number (%) | |||
| Quinolone and itraconazole | 6* | Not done | 4 | Successful therapy |
| > 1.0 | 1 | Successful therapy | ||
| > 1.0 | 1 | Lost to follow-up | ||
| Rifampicin and itraconazole | 6 | Not done | 3 | Successful therapy |
| < 0.5 | 1 | Death | ||
| < 0.5 | 1 | Relapse | ||
| < 0.5 | 1 | Successful therapy | ||
*
Three patients started with rifampicin and then changed to quinolone.